LM Advisors »

Royalty Pharma shares owned by LM Advisors

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by LM Advisors from 13F filings

Historical chart of LM Advisors investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by LM Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by LM Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $18k 683 25.88
2023-12-31 $10k 369 28.12

More positions owned by LM Advisors

Invesco Exch Trd Slf Idx Fd Rusl 1000 Dynm Etf (OMFL)
Spdr S&p 500 Etf Tr Tr Unit Etf (SPY)
Amazon (AMZN)
First Tr Exchng Traded Fd Vi Ft Vest Int Eq M Etf (YSEP)
Owl Rock Capital Corporation (OBDC)
BlackRock Insured Municipal Income Trust (BYM)
Alphabet Inc Cap Stk Cl C Cl C (GOOG)
Sofi Technologies (SOFI)
Apple (AAPL)
Vanguard Specialized Funds Div App Etf Etf (VIG)
Aberdeen Income Cred Strat (ACP)
First Tr Exchng Traded Fd Vi Ft Vest U.s Etf (XJUN)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt Etf (FFEB)
Vanguard Index Fds S&p 500 Etf Etf (VOO)
First Tr Exchange-traded Fd Smid Risng Etf Etf (SDVY)

View all positions for LM Advisors

Top funds holding Royalty Pharma

Capital Research and Management Company - Division 3
FMR
BlackRock
Baillie Gifford & Co
Adage Capital Partners GP
Swedbank AB
State Street Corporation
Vanguard Group
Geode Capital Management
Caledonia
Victory Capital Management
Jane Street
Northern Trust
Norges Bank Investment Management
Patient Capital Management

View all funds holding Royalty Pharma